Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 13, 2019 - Issue 9
Submit an article Journal homepage
83
Views
4
CrossRef citations to date
0
Altmetric
Original Research

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

Samar K. DarweeshEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0001-7428-4569View further author information
ORCID Icon,
Kadry ElsaeedGeneral Medicine, Hepatology and Gastroenterology Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
,
Heba OmarEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9707-1141View further author information
ORCID Icon,
Maissa El RazikyEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Wafaa ElakelEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Magdy ElserafyEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Sohier Ahmed IsmailNHTMRI, Cairo, EgyptView further author information
,
Ahmed A. GomaaTropical Medicine Department, El- Fayoum University, Cairo, EgyptView further author information
,
Mai MehrezHepatology-Internal Medicine Department, National Hepatology, and Tropical Medicine Research Institute, Cairo, EgyptView further author information
,
Mahamed El KassasEndemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, EgyptView further author information
,
Mohamed AbdullahMedical Research Division, National Research Center, Cairo, EgyptView further author information
,
Mohammed Kamal ShakerTropical Medicine Department, Ain Shams University, Cairo, EgyptView further author information
,
Gamal EsmatEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Yehia El shazlyGeneral Medicine, Hepatology and Gastroenterology Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
,
Wahid DossEndemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
&
Imam WakedHepatology Department, National Liver Institute, Menoufiya University, Shebeen EL Kom, EgyptView further author information
 show all
Pages 907-914 | Received 13 Feb 2019, Accepted 05 Jun 2019, Published online: 23 Jun 2019

References

  • Chhatwal J, Chen Q, Ayer T, et al. Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA. Aliment Pharmacol Ther. 2018 Apr;47(7):1023–1031. Epub 2018 Jan 29.
  • El-Akel W, El-Sayed MH, El Kassas M, et al. National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care. J Viral Hepat. 2017:1–6.
  • Elsharkawy A, Fouad R, El Akel W, et al. Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. Aliment PharmacolTher 2017;45:681–687. doi: 10.1111/apt.13923.
  • European Association for the Study of the Liver EASL recommendations on treatment of hepatitis C. 2014. J Hepatol. 2014 Aug;61(2):373–395.
  • American Association for the Study of Liver Diseases/Infectious Diseases Society of America/International Antiviral Society-USA Recommendations for testing, managing, and treating hepatitis C. [cited 2015 October 1]. Available from: http://www.hcvguidelines.org
  • Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19:1321–1324. [PubMed] [Google Scholar]
  • Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59:318–327, [PMC free article] [PubMed] [Google Scholar]
  • Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–176. [PubMed] [Google Scholar].
  • Kouyoumjian SP, Chemaitelly H, Abu-Raddad LJ. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions. Sci Rep. 2018;8: 1661. [PMC free article] [PubMed] [Google Scholar].
  • DAIDS Table for grading the severity of adult and pediatric adverse events (V.1.0). 2009. [cited 2019 April 7]. Available from: http://rsc.Tech-Res.com/safetyandpharmacovigilance/gradingtables.Aspx
  • European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017;66(1):153-194. doi: 10.1016/j.jhep.2016.09.001.
  • American Association for the Study of Liver Diseases (AASLD). Recommendations for testing, managing and treating hepatitis C. [cited 2016 Nov 3]. Available from: http://hcvguidelines.org
  • Omata M, Kanda T, Wei L, et al. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatol Int. 2016;10:702–726. [PMC free article] [PubMed] [Google Scholar].
  • Fontaine H, Hezode C, Zoulim F, et al. Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-monoinfected patients from the French observational cohort ANRS CO22 Hepather; Abstract LP28 presented at the 50th Annual Meeting of European Association for the Study of the Liver; Vienna, Austria, 2015.
  • Sulkowski MS, Gardiner DF, Rodriguez-Torres M, et al. AI444040 Study Group. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med. 2014;370(3):211–221.
  • Ahmed OA, Elsebaey MA, Fouad MHA, et al. Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection. Infect Drug Resist. 2018 Mar 28;11:441–445. eCollection 2018.
  • Shiha G, Soliman R, ElBasiony M3, et al. Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience. Hepatol Int. 2018 Jul;12(4):339–347. Epub 2018 Apr 16.
  • Dietz J1, Susser S1, Vermehren J1, et al. European HCV resistance study group. Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals. Gastroenterology. 2018 Mar;154(4):976–988.e4. Epub 2017 Nov 13.
  • El Kassas M, Funk AL, Salaheldin M, et al. Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis. J Viral Hepat. 2018 Jun;25(6):623–630. Epub 2018 Jan 24.
  • Waziry R, Hajarizadeh B, Grebely J, et al. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression. J Hepatol. 2017 Dec;67(6):1204–1212. Epub 2017 Aug 9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.